In June 2018, the prime minister asked for a clinically-led review of NHS access standards (CRS) to ensure they measure what matters most, both in optimising clinical outcomes and to patients.

This report sets out an approach to modernising and streamlining cancer waiting times standards, refocusing performance measures on the critical NHS Long Term Plan objective of earlier and faster diagnosis, while continuing to incentivise the best clinical care.